Clinical trial
ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males
NCT00277095 · Uromedica, Industry · Completed
Key facts
| NCT number | NCT00277095 |
|---|---|
| Title | ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males |
| Official title | Clinical Investigation of the ProACT Adjustable Continence Therapy for Treatment of Post-Prostatectomy Stress Urinary Incontinence |
| Acronym | ProACT |
| Lead sponsor | Uromedica, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Device |
| Interventions | ProACT (Adjustable Continence Therapy) |
| Enrollment | 123 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Dec 1, 2017 |
| First posted | Jan 13, 2006 |
| Last update posted | May 31, 2018 |
| Countries | Canada, New Zealand, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: